A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma

George W. Wright(National Cancer Institute), Louis M. Staudt(National Cancer Institute), Elaine H. Hurt(National Institutes of Health), Andreas Rosenwald(Comprehensive Cancer Center Mainfranken), Adrian Wiestner(National Institutes of Health), Bruce K. Tan(Northwestern University)
Proceedings of the National Academy of Sciences
August 4, 2003
10.1073/pnas.1732008100
Cited by 1,041

Related Papers

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
|Nature|2000|9.9k
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
|New England Journal of Medicine|2002|3.9k
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2018|2.3k
The Transcriptional Program in the Response of Human Fibroblasts to Serum
|Science|1999|2k
Stromal Gene Signatures in Large-B-Cell Lymphomas
|New England Journal of Medicine|2008|1.8k